In this article, we will discuss Durvalumab (Warnings-4). So, let’s get started.
In cases of suspected
immune-mediated adverse reactions, initiate appropriate workup to exclude alternative etiologies, including infection. Institute medical management promptly, including specialty consultation as
appropriate.